Daniel J. O’Connor is a 25+ year biotech executive specializing in oncology drug development and corporate turnarounds. As CEO of companies like Jubilant Therapeutics and Ambrx, he has a record of scaling clinical-stage enterprises, highlighted by the $2 billion acquisition of Ambrx under his leadership. He holds a J. D. from Penn State Dickinson Law.
Outside of his corporate roles, Daniel is a U. S. Marine Corps veteran who served as a Captain during Operation Desert Shield. A second-generation Irish American, he values home and family, is married with three sons, and mentions enjoying a cold beer at the end of the day.
Unique fact: Before his career in biotech, he served as a criminal prosecutor in Somerset County, New Jersey.
Read the full overview →They maintain good relationships with everyone, internally and externally. They are motivated by the potential impact of their decision on the organization. They are unlikely to become strong champions as they don't prefer pushing other people.
Steadiness (S) reflects the degree to which a person is likely to focus on cooperation, support and taking everyone along. Those scoring high tend to be consistent and calm.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.